A novel inflammatory bowel disease registry powered by artificial intelligence and natural language processing
Eine neuartige Registerdatenbank für entzündliche Darmerkrankungen mit künstlicher Intelligenz und Natural Language Processing
PLOS Digital Health · 27.08.2026 · 5 (8) · e0001603
DOI: 10.1371/journal.pdig.0001603 ↗Auf einen Blick
Die IBD Data Lake wurde entwickelt und validiert. Sie identifizierte IBD-Patient:innen mit hoher Genauigkeit und extrahierte klinische Daten aus strukturierten und unstrukturierten Quellen.
Fragestellung
Kann eine IBD-Registerdatenbank mit Machine Learning und NLP IBD-Patient:innen und klinische Merkmale aus Routinedaten zuverlässig erfassen?
Methode
Entwicklung und Validierung einer IBD-Repository; Extraktion strukturierter und unstrukturierter EMR-Daten in eine Cloud-Datenbank; Validierung gegen Chart Review als Goldstandard.
Ergebnisse
Zwischen 1. Juli 2018 und 31. Juli 2023 wurden 208 Patient:innen erfasst (104 IBD, 104 non-IBD). Für IBD-Erkennung: Sensitivität 98,1 %, Spezifität 97,1 %, Genauigkeit 97,6 %.
Schlussfolgerung der Autor:innen
Die IBD Data Lake wurde etabliert und validiert; Machine Learning und NLP ermöglichen eine umfassende und zeitnahe Datenextraktion.
Kernaussagen
- IBD-Erkennung mit hoher Genauigkeit
- UC/Crohn, Rauchen und extraintestinale Manifestationen wurden gut erkannt
- Grundlage für die Rekrutierung spezifischer IBD-Kohorten
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift PLOS Digital Health, online erschienen am 27.08.2026. Verfasst von Jeremy Liu Chen Kiow und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of British Columbia, Vancouver, Canada. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Despite substantial recent progress in inflammatory bowel disease (IBD) therapies, there remains a large proportion of patients who are non-responders or develop significant adverse events. Accurate data registries may assist clinicians and researchers to gain insights into IBD and provide opportunities to improve overall patient care. Most data registries are limited by the amount of time and resources needed to collect and record patient-level data. We describe and validate a novel IBD repository (IBD Data Lake), leveraging machine learning and natural language processing (NLP) techniques, as useful tools to curate and retrieve pertinent, real-time clinical data in the IBD population. Structured and unstructured data were extracted from patients’ electronic medical record and were transferred to a secure cloud infrastructure and curated into a searchable database. A customized user interface was created, and an advanced NLP service (Comprehend Medical) was employed to extract clinical information from unstructured data from medical documents. Chart review served as the gold standard for validation. Between July 1, 2018 and July 31, 2023, 208 (104 IBD and 104 matched non-IBD) patients were retrieved. The IBD Data Lake’s performance metrics for identifying IBD patients were as follows: sensitivity 98.1%, specificity 97.1%, and accuracy 97.6%. The machine learning/NLP components demonstrated high performance in analyzing key IBD characteristics: for distinction of ulcerative colitis or Crohn’s disease, sensitivity was 100% and specificity 98.2%; for smoking status, sensitivity was 100% and specificity 96.9%; and for extraintestinal manifestations, sensitivity was 92% and specificity 100%. A novel IBD Data Lake that integrates machine learning and NLP techniques has been established and validated. IBD patients were identified with high accuracy and the machine learning/NLP components enable comprehensive and timely data extraction. This will ultimately lay the groundwork for recruitment of specific IBD cohorts of interest to address the gaps that remain in our knowledge.
Autor:innen und Institutionen
- Department of Medicine, University of British Columbia, Vancouver, Canada.
- Division of Gastroenterology, St. Paul's Hospital, Vancouver, Canada.
- IBD Centre of BC, Vancouver, Canada.
- Division of Gastroenterology, Montreal University Hospital Centre (CHUM), Montreal, Canada.
- Department of Pediatrics, University of British Columbia, Vancouver, Canada.
- BC Children's Hospital Research Institute, Vancouver, Canada.
ORCID-Profile: Jeremy Liu Chen Kiow
Zitieren
APA
Liu Chen Kiow, J., Massaro, C., Jimenez, E. C., Kalisky, I., Lunken, G., Leung, Y., Bressler, B., & Rosenfeld, G. (2026). A novel inflammatory bowel disease registry powered by artificial intelligence and natural language processing. PLOS Digital Health, 5(8), e0001603. https://doi.org/10.1371/journal.pdig.0001603
Vancouver
Liu Chen Kiow J, Massaro C, Jimenez EC, Kalisky I, Lunken G, Leung Y, et al. A novel inflammatory bowel disease registry powered by artificial intelligence and natural language processing. PLOS Digital Health. 2026;5(8):e0001603. doi:10.1371/journal.pdig.0001603
BibTeX
@article{LiuChenKiow2026,
author = {Liu Chen Kiow, Jeremy and Massaro, Cristian and Jimenez, Efrain Cruz and Kalisky, Itay and Lunken, Genelle and Leung, Yvette and Bressler, Brian and Rosenfeld, Greg},
title = {A novel inflammatory bowel disease registry powered by artificial intelligence and natural language processing},
journal = {PLOS Digital Health},
year = {2026},
volume = {5},
number = {8},
pages = {e0001603},
doi = {10.1371/journal.pdig.0001603}
}
EUVIMED